FindTrial
Sign In

Abnormal Cisatracurium Pharmacodynamics and Pharmacokinetics among Patients with Severe Aortic Regurgitation during Anesthetic Induction

Abnormal Cisatracurium Pharmacodynamics and Pharmacokinetics among Patients with Severe Aortic Regurgitation during Anesthetic Induction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019654
Enrollment
Unknown
Registered
2018-11-20
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic regurgitation

Interventions

severe AR:cisatracurium
control:cisatracurium

Sponsors

Guangdong General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) aged 20-60 years old; (2) BMI 20-24 kg/m2; (3) American Society of Anesthesiologists grade I or II.

Exclusion criteria

Exclusion criteria: (1) history of allergy to cisatracurium; (2) compromised renal or liver function.

Design outcomes

Primary

MeasureTime frame
cisatracurium plasma concentration;TOF onset time;—

Countries

China

Contacts

Public ContactSheng Wang

Guangdong General Hospital

shengwang_gz@163.com+86 13560182353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026